Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharm CPR > ACS/Stable Angina > Flashcards

ACS/Stable Angina Flashcards

1
Q

What are your approaches to treating stable angina?

A
  1. Increase or restore coronary blood flow through
    - Surgery: CABG, PCI, Stent

Typically pharmacology is not helpful in increasing blood flow through the stenotic coronary artery into ischemic area

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Talk about the bioavailability of nitrates

A

Significant first pass metabolism means that bioavailability through oral route is low

Isosorbide mononitrate is a poor substrate of nitrate reductase that is characterized by high bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the mechanism of action of nitrates?

A

Organic nitrates get metabolically active -> forms NO -> cGMP -> PKG

PKG -> opens potassium channels to hyperpolarize and reduce calcium entry

PKG -> myosin-LC-dephosphorylation and relax smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the LEADING mechanism in stable angina?

A

Drop O2 demand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does tolerance develop in nitrates?

A

Through depletion of thiol compounds that normally release NO, now NO is stuck and helps form superoxide radicals. This means no vasodilation, and SNS activation now.

Drug free for 8 hours to be okay

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the adverse effects of nitrates?

A
  1. Headache (b/c meningeal vasodilation)
  2. Orthostatic hypotension
  3. Increase sympathetic discharge
  4. Increased renal Na+ and H2O reabsorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain the interaction between nitrates and PDE5 inhibitors?

A

cGMP increased with nitrates
“Fils” prevent breakdown of cGMP

BP drops hella

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the MOA of CCBs in stable angina?

A
  1. Decrease O2 demand
  2. Decrease PVR and afterload to drop BP - aftfects arterioles more than veins so less orthostatic hypotension
  3. Dihydropyridines work better

Drop contractility and HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the major risk associated with nifedipine?

A

MI in pts with HTN, slow release and long acting are better tolerated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When does vasodilation trigger reflex sympathetic activation?

A

Short acting Dihydropyridine CCBs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the cardioactive CCBs and what does this mean?

A

Diltiazem and Verapamil - slows HR because drops HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the MOA of Beta blockers?

A

Drop O2 demand

incidentally drops contractility and BP due to reduced afterload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some contraindications for beta blockers?

A

Asthma, PVD, Type 1 D, Bradyarrythmias, depressed function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the MOA of ranolazine?

A

Inhibit late Na+ current in cardiomyocytes targeting the LATE current by fast sodium channel responsible for phase 0 rapid depolarization

Pathologically NCX for Na/Ca remains open which brings in more calcium so we block this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does ranolazine NOT affect?

A

HR and peripheral hemodynamics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does ranolazine do?

A
  • Reduce diastolic tension (usually caused by increased calcium) and coronary vessel compression
  • Reduce cardiac contracitlity and O2 demand
17
Q

This drug is used for stable angina refractory to standard meds and to drop anginal episodes and improve exercise tolerance in patients taking nitrates, amlodipine, or atenolol

A

Ranolazine

18
Q

How do we treat stable angina?

A
  1. We try lipid lowering, lifestyle mods, nitrates, aspirin
  2. BB or CCB/nitrate next
  3. Add BB or CCB we didn’t add before, if we have low BP try the LA nitrate or ranolazine
  4. Consider triple therapy of BB, CCB, LA nitrate or ranolazine
  5. Consider CABG
19
Q

What are the bad effects of nitrates alone?

A

HR reflex increases

Contractility reflex increases

20
Q

What are the bad effects of BB and CCB? What happens when we add nitrates?

A

Increase EDV
Increase Ejection time

None of these bad effects!

21
Q

What do we do to treat vasospastic angina?

A
  1. CCBs (Diltiazem or Amlodipine)

2. If CCB contraindicated, we use long acting nitrates

22
Q

Local ischemia due to arterial occlusion and ACS leads to the formation of

A

White thrombus (platelet rich)

23
Q

Pain/swelliing, embolic strokes lead to the formation of

A

Red thrombus (fibrin-rich with trapped RBCs)

24
Q

Anticoagulants are used to prevent clots in the

A

Venous system (red thrombi)

25
Q

Antiplatelet drugs are used to prevent clots from forming in

A

Arteries (white thrombi)

26
Q

When do we treat with aspirin?

A

In acute coronary events as part of dual antiplatelet therapy with P2Y12 blocker OR secondary prevention of conary events with low dose aspirin

27
Q

What are the adverse effects associated with aspirin?

A

GI bleed, aspirin hypersensitivty

28
Q

What is the MOA of P2Y12 (ADP) receptor blockers?

A

ADP activates P2Y12 receptor, GPCR, inhibits adenyl cyclase to reduce cAMP levels - blocking will increase these levels and cAMP levels

29
Q

CYP2C19 is associated with what drug resistance

A

Clopidogrel - half of Chinese people have this resistance, then AAs, whites, mexicans

30
Q

When do we start someone on P2Y12 receptor blocker?

A

ASAP in acute coronary events with dual therapy
Used alone if aspirin hypersensitivity
Secondary prevention in patients with ACS hx

31
Q

What are the adverse effects of P2Y12 blockers?

A

Minor and major bleeding complications

32
Q

MOA of GP IIb/IIIa inhibitors?

A

Prevents binding of ligands to GP IIb/IIIa receptor to inhibit platelet aggregation

33
Q

This drug is indicated during PCI in high risk patients

A

Glycoprotein IIB/IIIA inhibitors

34
Q

What are the adverse effects of GP IIB/IIIA inhibitors?

A

Bleeding (CKD)

Thrombocytopenia (seen with abciximab)

35
Q

MOA of streptokinase

A

Binds plasminogen to activate it

36
Q

MOA of “plase”

A

Cleave plasminogen to convert to plasmin

37
Q

Use these drugs if PCI cannot be performed timely manner

A

Thrombolytics

38
Q

Used in STEMI or NSTEMI within 12 hours after onset of symptoms

A

Thrombolytics

39
Q

What are adverse effects associated with fibrinolytic drugs?

A

Bleeding and allergic reactions (streptokinase)

Pharm CPR (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions